ZA200904921B - Methods and compositions for treating IL-4 or IL-13 related fibrosis related pathologies - Google Patents

Methods and compositions for treating IL-4 or IL-13 related fibrosis related pathologies

Info

Publication number
ZA200904921B
ZA200904921B ZA200904921A ZA200904921A ZA200904921B ZA 200904921 B ZA200904921 B ZA 200904921B ZA 200904921 A ZA200904921 A ZA 200904921A ZA 200904921 A ZA200904921 A ZA 200904921A ZA 200904921 B ZA200904921 B ZA 200904921B
Authority
ZA
South Africa
Prior art keywords
compositions
treating
methods
pathologies
fibrosis
Prior art date
Application number
ZA200904921A
Other languages
English (en)
Inventor
Lynne A Murray
Original Assignee
Centocor Ortho Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc
Publication of ZA200904921B publication Critical patent/ZA200904921B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200904921A 2006-12-15 2009-07-14 Methods and compositions for treating IL-4 or IL-13 related fibrosis related pathologies ZA200904921B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87010506P 2006-12-15 2006-12-15

Publications (1)

Publication Number Publication Date
ZA200904921B true ZA200904921B (en) 2010-09-29

Family

ID=39536976

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904921A ZA200904921B (en) 2006-12-15 2009-07-14 Methods and compositions for treating IL-4 or IL-13 related fibrosis related pathologies

Country Status (13)

Country Link
US (1) US20100008914A1 (fr)
EP (1) EP2125037A2 (fr)
JP (1) JP2010513301A (fr)
KR (1) KR20090101924A (fr)
CN (1) CN101646465A (fr)
AU (1) AU2007334022A1 (fr)
BR (1) BRPI0721170A2 (fr)
CA (1) CA2672878A1 (fr)
EA (1) EA200970588A1 (fr)
IL (1) IL199347A0 (fr)
MX (1) MX2009006457A (fr)
WO (1) WO2008076784A2 (fr)
ZA (1) ZA200904921B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8092804B2 (en) 2007-12-21 2012-01-10 Medimmune Limited Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
EP3235508B1 (fr) * 2011-03-16 2020-12-30 Sanofi Compositions comprenant une protéine double de type anticorps de région variable
US10232039B2 (en) 2011-04-12 2019-03-19 Duke University Compositions and methods for the treatment of tissue fibrosis
CN111518211B (zh) 2018-12-25 2022-06-21 江苏荃信生物医药股份有限公司 抗人白介素4受体α单克隆抗体的制药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664227B1 (en) * 1996-03-01 2003-12-16 Genetics Institute, Llc Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
US7666411B2 (en) * 2002-06-14 2010-02-23 The United States Of America As Represented By The Department Of Health And Human Services Methods of treating and preventing colitis involving IL-13 and NK-T cells

Also Published As

Publication number Publication date
WO2008076784A2 (fr) 2008-06-26
AU2007334022A1 (en) 2008-06-26
WO2008076784A3 (fr) 2008-10-23
EP2125037A2 (fr) 2009-12-02
US20100008914A1 (en) 2010-01-14
CA2672878A1 (fr) 2008-06-26
MX2009006457A (es) 2009-08-25
IL199347A0 (en) 2010-03-28
CN101646465A (zh) 2010-02-10
JP2010513301A (ja) 2010-04-30
KR20090101924A (ko) 2009-09-29
BRPI0721170A2 (pt) 2014-03-18
EA200970588A1 (ru) 2009-12-30

Similar Documents

Publication Publication Date Title
EP1720573A4 (fr) Procedes et compositions pour traiter des pathologies associees a l'il-13
ZA200810074B (en) Cleaning and/or treatment compositions comprising mutant alpha-amylases
EP2224924A4 (fr) Compositions et procédés destinés au traitement de la fibrose kystique
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
EP2066687A4 (fr) Compositions et procédés servant à inhiber l'expression du gène hamp
EP2101731A4 (fr) Procédés et compositions d'endoxifène
IL198310A0 (en) Compositions and method for hair loss prevention
EP2037743A4 (fr) Compositions de pâte et procédés associés
EP2046129A4 (fr) Composition herbicide et son procédé d'utilisation
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
EP2034841A4 (fr) Méthodes et préparations pour le traitement de biofilms
PL1816116T6 (pl) Kompozycje chemiczne i sposoby ich wytwarzania
EP2088865A4 (fr) Procédés et compositions autour de guggulphospholipides
EP2046128A4 (fr) Composition herbicide et son procédé d'utilisation
PT2007895E (pt) Construção
GB0617171D0 (en) Novel compositions and methods
GB0619500D0 (en) Treatment of fibrosis
EP2046116A4 (fr) Composition herbicide et son procédé d'utilisation
GB0601950D0 (en) Compositions and methods of treating diabetes
ZA200904921B (en) Methods and compositions for treating IL-4 or IL-13 related fibrosis related pathologies
IL192564A0 (en) Composition and method of use thereof
EP2132251A4 (fr) Composition et procédé
PL2046118T3 (pl) Kompozycja chwastobójcza i sposób jej stosowania
GB0625208D0 (en) Composition and method